Skip to content
Disclosery

Nextech Invest Ltd.

Follow

13F filer, CIK 1911010, Zurich, Switzerland

Nextech Invest Ltd. reported $616,414,127 across 15 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14. Its ten largest share positions make up 93.61% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-014109

Period
2024-12-31
Reported value
$616M
Holdings
15
Top 10 weight
93.61%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RVMDadded+1,304,347$57.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPRYreduced-176,300-$1.86M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001104659-25-014109, largest first. % of portfolio is the value over $616,414,127, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 4,839,529 shares; 2023Q2: 4,839,529 shares; 2023Q3: 4,839,529 shares; 2023Q4: 6,296,740 shares; 2024Q1: 6,296,740 shares; 2024Q2: 6,296,740 shares; 2024Q3: 6,296,740 shares; 2024Q4: 7,601,087 shares 7,601,087$332M53.94%+1,304,347Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 2,518,582 shares; 2023Q2: 2,518,582 shares; 2023Q3: 2,518,582 shares; 2023Q4: 2,518,582 shares; 2024Q1: 4,055,861 shares; 2024Q2: 4,055,861 shares; 2024Q3: 4,055,861 shares; 2024Q4: 4,055,861 shares 4,055,861$56.4M9.15%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: 4,285,714 shares; 2023Q3: 4,285,714 shares; 2023Q4: 4,285,714 shares; 2024Q1: 5,285,714 shares; 2024Q2: 5,285,714 shares; 2024Q3: 5,285,714 shares; 2024Q4: 5,285,714 shares 5,285,714$42.7M6.92%0Timeline
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 2,642,502 shares; 2024Q1: 2,642,502 shares; 2024Q2: 2,642,502 shares; 2024Q3: 2,642,502 shares; 2024Q4: 2,642,502 shares 2,642,502$38.1M6.18%0
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 287,251 shares; 2023Q2: 287,251 shares; 2023Q3: 287,251 shares; 2023Q4: 1,695,645 shares; 2024Q1: 1,408,394 shares; 2024Q2: 1,408,394 shares; 2024Q3: 1,408,394 shares; 2024Q4: 1,408,394 shares 1,408,394$27M4.38%0Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 5,978,327 shares; 2024Q1: 3,856,321 shares; 2024Q2: 9,526,146 shares; 2024Q3: 12,067,246 shares; 2024Q4: 12,067,246 shares 12,067,246$17.3M2.8%0
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 5,533,980 shares; 2023Q4: 5,533,980 shares; 2024Q1: 5,533,980 shares; 2024Q2: 5,533,980 shares; 2024Q3: 5,533,980 shares; 2024Q4: 5,533,980 shares 5,533,980$17.1M2.77%0Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 1,113,946 shares; 2024Q4: 1,113,946 shares 1,113,946$16.3M2.65%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 625,485 shares; 2023Q2: 948,659 shares; 2023Q3: 1,196,409 shares; 2023Q4: 1,346,409 shares; 2024Q1: 3,846,409 shares; 2024Q2: 3,846,409 shares; 2024Q3: 3,846,409 shares; 2024Q4: 3,846,409 shares 3,846,409$15.8M2.57%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 1,221,145 shares; 2023Q2: 1,221,145 shares; 2023Q3: 1,221,145 shares; 2023Q4: 1,221,145 shares; 2024Q1: 1,221,145 shares; 2024Q2: 1,221,145 shares; 2024Q3: 1,141,145 shares; 2024Q4: 1,141,145 shares 1,141,145$13.9M2.25%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 1,476,998 shares; 2024Q4: 1,476,998 shares 1,476,998$11.6M1.88%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 1,910,029 shares; 2023Q2: 1,910,029 shares; 2023Q3: 1,910,029 shares; 2023Q4: 1,910,029 shares; 2024Q1: 1,910,029 shares; 2024Q2: 1,910,029 shares; 2024Q3: 1,113,029 shares; 2024Q4: 936,729 shares 936,729$9.88M1.6%-176,300Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 7,419,355 shares; 2024Q3: 7,419,355 shares; 2024Q4: 7,419,355 shares 7,419,355$7.79M1.26%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 952,400 shares; 2024Q2: 952,400 shares; 2024Q3: 952,400 shares; 2024Q4: 952,400 shares 952,400$6.55M1.06%0Timeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,228,069 shares; 2024Q2: 1,228,069 shares; 2024Q3: 1,228,069 shares; 2024Q4: 1,228,069 shares 1,228,069$3.56M0.58%0Timeline

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-25-014109 base2025-02-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001104659-25-014109 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001104659-24-118949 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001104659-24-089665 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001104659-24-061963 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001104659-24-023793 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001104659-23-117490 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001104659-23-091377 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001104659-23-059762 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001104659-23-020685 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001104659-22-118489 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001104659-22-084692 Quarter ended 2022-06-302022-08-01acceptance time not in the bulk data set
13F-HR 0001104659-22-060901 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR/A 0001104659-22-060818 Quarter ended 2021-12-312022-05-16acceptance time not in the bulk data set
13F-HR 0001104659-22-022977 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set